Clinical Trial Update: Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD) [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety study of desvenlafaxine succinate sustained release in Japanese adults with major depressive disorder has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Desvenlafaxine succinate sustained-release (Desvenlafaxine)

Snippet

Sponsor: Pfizer | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2012-01-30